2017-03-20,Aralez CEO Purchases 500,000 Shares Of Company Common Stock On Open Market
2017-03-15,Biotech Premarket Movers: Arena, Immunomedics, Aralez
2017-03-13,Biotech Premarket Movers: Cempra, Blueprint Medicines, Aralez
2017-02-27,Aralez To Announce Fourth Quarter And Full-Year 2016 Results On March 13, 2017
2017-02-16,Aralez To Present At The RBC Capital Markets Global Healthcare Conference
2017-02-13,Aralez To Ring Closing Bell At Nasdaq On February 14, 2017
2017-01-27,Premarket Biotech Movers: Neurocrine Biosciences, Aralez Pharmaceuticals, Qiagen
2017-01-25,First Week of ARLZ February 17th Options Trading
2017-01-19,Aralez Pharmaceuticals is Now Oversold (ARLZ)
2017-01-11,Biotech Premarket Movers: IPXL, SGMO, ARLZ
2017-01-11,Aralez Announces Issuance Of Additional U.S. Patent For Yosprala
2017-01-09,Aralez Submits Marketing Authorization Application To The European Medicines Agency For PA10040
2017-01-09,Aralez Provides Update On PBM Formulary Status For Yosprala
2016-12-19,Aralez Added To The NASDAQ Biotechnology Index
2016-12-19,Aralez Announces Commercial Launch Of BLEXTEN™ In Canada
2016-12-15,Aralez Provides Update On PBM Formulary Status For Yosprala
2016-11-30,Aralez To Participate At Two Upcoming Healthcare Conferences
2016-11-02,Aralez To Present At The Jefferies London Healthcare Conference
2016-10-31,Aralez Completes Acquisition Of Toprol-XL® And Its Authorized Generic From AstraZeneca
2016-10-24,Aralez To Announce Third Quarter 2016 Results On November 7, 2016
2016-10-04,Aralez To Acquire From AstraZeneca U.S. Rights To Beta Blocker Toprol-XL®
2016-10-03,Aralez Announces U.S. Commercial Launch Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers
2016-09-30,Interesting ARLZ Put And Call Options For November 18th
2016-09-15,Aralez Pharmaceuticals (ARLZ) Stock Closed Higher on Yosprala FDA Approval
2016-09-15,Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers
2016-09-07,Aralez Pharmaceuticals (ARLZ) Stock Advances, Buys Drug Rights from Merck
2016-09-07,Aralez Acquires United States And Canadian Rights To ZONTIVITY From Merck
2016-08-22,Interesting ARLZ Put And Call Options For October 21st
2016-07-26,Aralez To Announce Second Quarter 2016 Results On August 9, 2016
2016-07-06,Aralez To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference
2016-06-02,Aralez To Present At The Jefferies Healthcare Conference
2016-05-24,Insider Trading Alert - UDR, ARLZ And SMLP Traded By Insiders
2016-05-16,Aralez Distributes Meeting Materials For 2016 Annual General Meeting Of Shareholders
2016-04-28,Aralez To Present At The Deutsche Bank 41st Annual Healthcare Conference
2016-04-28,Aralez To Announce First Quarter 2016 Results On May 10, 2016
2016-04-25,Aralez To Present At The Bloom Burton & Co. Healthcare Investor Conference
2016-04-25,Aralez Receives Health Canada Approval For BLEXTEN™
2016-04-20,Aralez Announces Several Corporate Updates
2016-04-19,Aralez Appoints James L. Hall As General Manager Of Canadian Business
2016-04-19,First Week of ARLZ December 16th Options Trading
2016-04-08,Insider Trading Alert - VLGEA, ARLZ And GGP Traded By Insiders
2016-04-04,Aralez To Open Toronto Stock Exchange On April 5, 2016
2016-03-28,Aralez Announces FDA Acceptance Of New Drug Application For YOSPRALA™
2016-03-15,Relative Strength Alert For Aralez Pharmaceuticals
2016-03-15,Aralez Resubmits To FDA New Drug Application For YOSPRALA
2016-03-01,Aralez To Announce Fourth Quarter And Full-Year 2015 Results On March 15, 2016
2016-02-22,Aralez To Present At The Cowen And Company 36th Annual Healthcare Conference
2016-02-12,Aralez To Ring Closing Bell At Nasdaq On February 16, 2016
,
,
,
,
